
OLD Category: signatures
September 1, 2020 / Cancers (Basel)
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
September 1, 2020 / Cancers (Basel)
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge
September 1, 2020 / JCO Precision Oncology
Two cases of advanced stage lung adenocarcinoma with radiological complete response to nivolumab treatment harboring a STK11/LKB1 mutation
August 31, 2020 / J Cancer Res Clin Oncol
UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines
August 30, 2020 / Oncoimmunology
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
August 28, 2020 / Aging Cell
Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue
August 28, 2020 / Breast Cancer Res Treat
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
August 28, 2020 / BMC Med Genomics